The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2008GDNF Fusion Protein for Blood-Brain Barrier Delivery and Treatment in Parkinson's Disease
Objective/Rationale:
GDNF is a naturally occurring protein in the brain that protects and rescues the part of the brain that degenerates in Parkinson’s disease (PD). However, GDNF does not cross the...
-
MJFF Research Grant, 2008The anatomic basis of cardiac and cognitive changes in Parkinson's disease: A collaborative study with the Parkinson's Institute, Sunnyvale, CA (USA)
Objective/Rationale:
The heart, particularly the conduction system, is influenced by the parasympathetic and sympathetic nervous systems. Recently, early-occurring Parkinson’s disease-related Lewy... -
Program-non-specific Funding, 2008Evaluation of Pioglitazone CSF Penetration
Promising Outcomes of Original Grant:
In our original grant we assessed whether the antidiabetic compound pioglitazone can be neuroprotective in a non-human primate model of Parkinson’s disease. We... -
Program-non-specific Funding, 2008Evaluation of Neuroprotective Properties of Selective PPAR Gamma Agonist LY554862
Objective/Rationale:
Low-risk, easily administered therapies aiming to slow down or stop neurodegeneration in PD are urgently needed. Compounds that activate PPAR gamma receptors have the potential to... -
MJFF Research Grant, 2008Evaluation of Gastrointestinal Motility in Parkinsonian Rodents
Objective/Rationale:
Gastrointestinal (GI) symptoms, such as nausea, bloating, and constipation occur in nearly every patient afflicted with Parkinson’s Disease (PD) at some point in their illness... -
MJFF Research Grant, 2008Are Anti-Parkinsonian Treatments Disease Modifying?
Objective/Rationale:
Current treatments of Parkinson’s disease are not thought to slow the progression of the disease but just appear to result in temporary relief of symptoms. There is some evidence...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.